Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin in Idiopathic Small Fiber Neuropathy
NCT02607254Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Sep 2015
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pregabalin in idiopathic small fiber neuropathy (ISFN), sponsored by Johns Hopkins University. Started Sep 2015; status: completed.
02
Drugs
pregabalin
03
Conditions
idiopathic small fiber neuropathy (ISFN)
Beyond the preview
Go deeper on NCT02607254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02607254.